These findings reveal a role for p53 in regulating SQLE and other relevant genes to control cholesterol biosynthesis, at distinct points along this critical metabolic pathway and further demonstrate that its down-regulation is critical for p53-mediated tumor suppression [9–12]. Here, TP53 is linked to neoplasm.